Back

Y-mAbs Therapeutics Stock Predictions

Sell

YMAB
Y-mAbs Therapeutics

Last Price:

11.76

Seasonality Move:

11.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Y-mAbs Therapeutics Stock Forecast

Over the next 52 weeks, Y-mAbs Therapeutics has on average historically risen by 4.7% based on the past 5 years of stock performance.
Y-mAbs Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Is Y-mAbs Therapeutics Stock Undervalued?
The current Y-mAbs Therapeutics [YMAB] share price is $12.18. The Score for YMAB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
YMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Y-mAbs Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Y-mAbs Therapeutics has on average historically risen by 4.7% based on the past 5 years of stock performance.

Y-mAbs Therapeutics Stock Rating

Sell

Y-mAbs Therapeutics (YMAB) is a Sell

Is Y-mAbs Therapeutics overpriced?

Y-mAbs Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Y-mAbs Therapeutics Stock Price History

Is YMAB stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

ymabs.com

52-Week Data

52-Week High:

20.90

52-Week Low:

4.60

Prediction Charts

Market Cap:

534.49M

Price in USD:

12.18

Volume:

267.46K

Beta:

0.84

Technical Analysis

SMA50:

15.21

SMA100:

13.52

SMA200:

9.54

52-Wk Change:

18.48%

Stock Predictions

Is Y-mAbs Therapeutics stock public?
Yes, Y-mAbs Therapeutics is a publicly traded company.
What is the Y-mAbs Therapeutics stock quote today?
The Y-mAbs Therapeutics stock price is 12.18 USD today.
How to buy Y-mAbs Therapeutics stock online?
You can buy Y-mAbs Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-26	14.92	14.71	15.13	14.36
Apr-29	14.81	15.50	15.57	14.64
Apr-30	15.29	15.23	15.56	14.98
May-1	15.36	16.46	17.00	15.36
May-2	16.49	17.26	17.39	16.30
May-3	17.50	17.15	17.78	16.99
May-6	17.15	17.24	17.38	16.80
May-7	17.24	17.24	17.47	16.98
May-8	15.54	13.61	15.54	12.90
May-9	13.58	12.87	14.44	12.75
May-10	12.96	12.28	12.96	11.91
May-13	12.28	12.19	12.55	11.83
May-14	12.24	11.82	12.70	11.52
May-15	12.03	12.18	12.75	12.03

Y-mAbs Therapeutics Earnings

Y-mAbs Therapeutics Earnings Report: Per Share Y-mAbs Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Y-mAbs Therapeutics Forecast Revenue Growth

Y-mAbs Therapeutics Stock Analysis: Historical quarterly revenues per share for Y-mAbs Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.07 per share, an increase this year of $0.22 per share, and an increase next year of $0.29 per share.

* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.